Dexamethasone pretreatment alleviates intestinal ischemia–reperfusion injury

Stefanutti, 2005, Moderate hypothermia protects against systemic oxidative stress in a rat model of intestinal ischemia and reperfusion injury, Shock, 24, 159, 10.1097/01.shk.0000168871.60531.6f Schoots, 2004, Systematic review of survival after acute mesenteric ischaemia according to disease aetiology, Br J Surg, 91, 17, 10.1002/bjs.4459 Acosta-Merida, 2006, Identification of risk factors for perioperative mortality in acute mesenteric ischemia, World J Surg, 30, 1579, 10.1007/s00268-005-0560-5 Bischoff, 2007, Human mast cells, bacteria, and intestinal immunity, Immunol Rev, 217, 329, 10.1111/j.1600-065X.2007.00523.x Bischoff, 2009, Physiological and pathophysiological functions of intestinal mast cells, Semin Immunopathol, 31, 185, 10.1007/s00281-009-0165-4 Klooker, 2010, The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome, Gut, 59, 1213, 10.1136/gut.2010.213108 Andoh, 2001, Role of complement activation and mast cell degranulation in the pathogenesis of rapid intestinal ischemia/reperfusion injury in rats, Digestion, 63, 103, 10.1159/000051920 Hei, 2008, Influence of ketotifen, cromolyn sodium, and compound 48/80 on the survival rates after intestinal ischemia reperfusion injury in rats, BMC Gastroenterol, 8, 42, 10.1186/1471-230X-8-42 Kalia, 2005, Ketotifen abrogates local and systemic consequences of rat intestinal ischemia-reperfusion injury, J Gastroenterol Hepatol, 20, 1032, 10.1111/j.1440-1746.2005.03767.x Tokudome, 2009, Glucocorticoid protects rodent hearts from ischemia/reperfusion injury by activating lipocalin-type prostaglandin D synthase-derived PGD2 biosynthesis, J Clin Invest, 119, 1477, 10.1172/JCI37413 Felszeghy, 2004, Dexamethasone downregulates chemokine receptor CXCR4 and exerts neuroprotection against hypoxia/ischemia-induced brain injury in neonatal rats, Neuroimmunomodulation, 11, 404, 10.1159/000080151 Feng, 2011, Dexamethasone pre-treatment protects brain against hypoxic-ischemic injury partially through up-regulation of vascular endothelial growth factor A in neonatal rats, Neuroscience, 179, 223, 10.1016/j.neuroscience.2011.01.050 Kumar, 2009, Dexamethasone ameliorates renal ischemia-reperfusion injury, J Am Soc Nephrol, 20, 2412, 10.1681/ASN.2008080868 Chatterjee, 2007, Synergistic therapeutic potential of dexamethasone and L-arginine in lipopolysaccharide-induced septic shock, J Surg Res, 140, 99, 10.1016/j.jss.2006.09.002 Vieira, 2005, Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury, Br J Pharmacol, 146, 244, 10.1038/sj.bjp.0706321 Shin, 2009, Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes, J Immunol, 182, 647, 10.4049/jimmunol.182.1.647 Kim, 2013, Activation of NF-κb pathway in oral buccal mucosa during small intestinal ischemia-reperfusion injury, J Surg Res, 179, 99, 10.1016/j.jss.2012.08.028 Chiu, 1970, Intestinal mucosal lesion in low-flow states. I. A morphological, hemodynamic, and metabolic reappraisal, Arch Surg, 101, 478, 10.1001/archsurg.1970.01340280030009 Abraham, 2000, Neutrophils as early immunologic effectors in hemorrhage- or endotoxemia-induced acute lung injury, Am J Physiol Lung Cell Mol Physiol, 279, L1137, 10.1152/ajplung.2000.279.6.L1137 Abraham, 1999, Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation, Am J Physiol, 276, L1 Tang, 2005, Amelioration of the development of multiple organ dysfunction syndrome by somatostatin via suppression of intestinal mucosal mast cells, Shock, 23, 470, 10.1097/01.shk.0000160522.29482.df He, 2004, Key role of mast cells and their major secretory products in inflammatory bowel disease, World J Gastroenterol, 10, 309, 10.3748/wjg.v10.i3.309 Castells, 1987, Evaluation of human peripheral blood leukocytes for mast cell tryptase, J Immunol, 138, 2184, 10.4049/jimmunol.138.7.2184 Huygen, 2004, Mast cells are involved in inflammatory reactions during complex regional pain syndrome type 1, Immunol Lett, 91, 147, 10.1016/j.imlet.2003.11.013 Yamamoto, 2001, The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia-reperfusion injury of the rat small intestine, J Surg Res, 99, 134, 10.1006/jsre.2001.6106 Szabo, 1997, The role of mast cells in mucosal permeability changes during ischemia-reperfusion injury of the small intestine, Shock, 8, 284, 10.1097/00024382-199710000-00008 Samtani, 2005, Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration, Biopharm Drug Dispos, 26, 85, 10.1002/bdd.435 Boros, 1999, The role of mast cell degranulation in ischaemia-reperfusion-induced mucosal injury in the small intestine, Ann Acad Med Singapore, 28, 79 Jiang, 2011, Mast cells drive mesenteric afferent signalling during acute intestinal ischaemia, J Physiol, 589, 3867, 10.1113/jphysiol.2011.209478 McNeil, 1992, Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7, Proc Natl Acad Sci U S A, 89, 11174, 10.1073/pnas.89.23.11174 Funaba, 2003, Transcriptional activation of mouse mast cell protease-7 by activin and transforming growth factor-beta is inhibited by microphthalmia-associated transcription factor, J Biol Chem, 278, 52032, 10.1074/jbc.M306991200 Okayama, 2006, Development, migration, and survival of mast cells, Immunol Res, 34, 97, 10.1385/IR:34:2:97 Caughey, 2007, Mast cell tryptases and chymases in inflammation and host defense, Immunol Rev, 217, 141, 10.1111/j.1600-065X.2007.00509.x Abraham, 2010, Mast cell-orchestrated immunity to pathogens, Nat Rev Immunol, 10, 440, 10.1038/nri2782 Nosal'ova, 2008, Effect of H1 antihistamines in a model of mesenteric ischaemia/reperfusion, Inflamm Res, 57, S55, 10.1007/s00011-007-0627-x Gan, 2011, Mast-cell-releasing tryptase triggers acute lung injury induced by small intestinal ischemia-reperfusion by activating Par-2 in rats, Inflammation Kawabata, 2000, Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles, Jpn J Pharmacol, 82, 171, 10.1254/jjp.82.171 Berger, 2001, Tryptase and agonists of PAR-2 induce the proliferation of human airway smooth muscle cells, J Appl Physiol, 91, 1372, 10.1152/jappl.2001.91.3.1372 Compton, 1998, J Immunol, 161, 1939, 10.4049/jimmunol.161.4.1939 Yoshida, 2011, Proinflammatory role of protease-activated receptor-2 in intestinal ischemia/reperfusion injury in rats, Mol Med Rep, 4, 81 Yao, 1996, Monoclonal antibody to tumor necrosis factor-alpha attenuates hemodynamic dysfunction secondary to intestinal ischemia/reperfusion in rats, Crit Care Med, 24, 1547, 10.1097/00003246-199609000-00020